LIHE PHARM TECHNOLOGY (WUHAN) CO.,LTD

SAFE DELIVERY,BETTER QUALITY,LOWER PRICE

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsPharma Raw Material

Powder Pharma Raw Material 99.9% CAS 148553-50-8

Powder Pharma Raw Material 99.9% CAS 148553-50-8

Powder Pharma Raw Material 99.9% CAS 148553-50-8
Powder Pharma Raw Material 99.9% CAS 148553-50-8 Powder Pharma Raw Material 99.9% CAS 148553-50-8 Powder Pharma Raw Material 99.9% CAS 148553-50-8

Large Image :  Powder Pharma Raw Material 99.9% CAS 148553-50-8

Product Details:
Place of Origin: China
Brand Name: LIHE
Certification: GMP, ISO
Model Number: 148553-50-8
Payment & Shipping Terms:
Minimum Order Quantity: 10g
Price: US $1-8 / g
Packaging Details: Drum / Aluminum Foil Bag / According to customer's requiement
Delivery Time: 1-3 working days
Payment Terms: L/C, D/A, D/P, T/T, Bitcoin
Supply Ability: 10000kgs/Month
Detailed Product Description
MF:: C8H17NO2 MW:: 159.23
EINECS:: 604-639-1 Melting Point: 194-196°C
Boiling Point: 274.0±23.0 °C(Predicted) Pka: 4.23±0.10(Predicted)
High Light:

99.9 pure Pharma Raw Material

,

148553-50-8 Lyrica Powder

,

Lyrica Powder Pharma Raw Material

Powder Pharma Raw Material 99.9% CAS 148553-50-8

 

 

Porduct Description:

 

CAS No: 148553-50-8
Molecular formula: C12H16N2S
EINECS No.: 230-902-1
Melting point: 140 C
Boiling point: 334.2±52.0 °C(Predicted)
Place of Origin: China
Type: Pharmaceutical intermediates
Appearance: Powder
Color White
Purity: 99.9%
Packing: 25kg/cartoon box
Application: API Raw Powder
Storage: -20°C
Sample: Available
Shelf life: 2 years

 

 

 

Related Product:

 

Product's Name CAS Purity
BMK Glycidic Acid (sodium salt) 5449-12-7 99%
4'-Methylpropiophenone 5337-93-9 99%
1,4-Butanediol 110-63-4 99%
4,4-Piperidinediol hydrochloride 40064-34-4 99%
N-(tert-Butoxycarbonyl)-4-piperidone 79099-07-3 99%
1-BOC-4-(4-FLUORO-PHENYLAMINO)-PIPERIDINE 288573-56-8 99%
PMK ethyl glycidate 28578-16-7 99%
N-METHYLBENZAMIDE 613-93-4 99%
Methylamine hydrochloride 593-51-1 99%
2-iodo-1-p-tolyl-propan-1-one 236117-38-7 99%
2-BROMO-1-PHENYL-PENTAN-1-ONE 49851-31-2 99%
Diethyl(phenylacetyl)malonate 20320-59-6 99%
PMK ethyl glycidate 28578-16-7 99%


Description:

 

It is a second- generation antiepileptic drug (AED) known with the proprietary brand name of Lyrica® (Pfizer, Tadworth) in the UK and USA (Pfizer, New York, NY).

 

 

Indications:

 

Epilepsy
Adjunctive therapy of focal seizures with and without secondary generalization.

Recommendations summarized from NICE (2012)

  • Seizure types—on referral to tertiary care (focal seizures), contraindicated (generalized tonic- clonic seizures, tonic/ atonic seizures, absence seizures, myoclonic seizures).
  • Epilepsy types—on referral to tertiary care (benign epilepsy with centrotemporal spikes, panayiotopoulos syndrome, late- onset childhood occipital epilepsy), contraindicated (absence syndromes, idiopathic generalized epilepsy, juvenile myoclonic epilepsy, Dravet syndrome, Lennox– Gastaut syndrome).


Psychiatry
Generalized anxiety disorder.

Neurology
Peripheral and central neuropathic pain

 

 

Functions and Applications:

 

It is used to treat oral ulcers.It's not used very often as a cardiac arrhythmic drug because of concerns about long-term side effects.A few people are allergic to lido caine.It was used in 1963 for the treatment of arrhythmia. It is the drug of choice for the prevention and treatment of acute myocardial infarction and various heart diseases complicated by rapid ventricular arrhythmia. It is the drug of choice for ventricular premature beats of acute myocardial infarction, ventricular tachycardia and ventricular tremor.It is suitable for acute ventricular arrhythmias caused by acute myocardial infarction, surgery, digitalis poisoning and cardiac catheterization, including premature ventricular beats, ventricular tachycardia and ventricular fibrillation.Second, it is also used for the status of epilepsy with other anticonvulsants and local or intra-vertebral anesthesia.It can also relieve tinnitus.

 
 
Deatailed Photoes
 

Powder Pharma Raw Material 99.9% CAS 148553-50-8 0

 

 

Packing and Delivery:

.Powder Pharma Raw Material 99.9% CAS 148553-50-8 1Powder Pharma Raw Material 99.9% CAS 148553-50-8 2Powder Pharma Raw Material 99.9% CAS 148553-50-8 3

Powder Pharma Raw Material 99.9% CAS 148553-50-8 4

Contact Details
LIHE PHARM TECHNOLOGY(WUHAN) CO.,LTD

Contact Person: Resse

Tel: +8618186115724

Send your inquiry directly to us (0 / 3000)